These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8822921)

  • 21. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
    Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
    Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3.
    Dolzhanskiy A; Basch RS; Karpatkin S
    Blood; 1997 Jan; 89(2):426-34. PubMed ID: 9002944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
    Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice.
    Ku H; Yonemura Y; Kaushansky K; Ogawa M
    Blood; 1996 Jun; 87(11):4544-51. PubMed ID: 8639822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.
    Ramsfjell V; Borge OJ; Veiby OP; Cardier J; Murphy MJ; Lyman SD; Lok S; Jacobsen SE
    Blood; 1996 Dec; 88(12):4481-92. PubMed ID: 8977240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
    Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
    Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein 130 and c-kit signals synergistically induce thrombopoietin production by hematopoietic cells.
    Matsui A; Sato T; Maekawa T; Asano S; Nakahata T; Tsuji K
    Int J Hematol; 2000 Dec; 72(4):455-62. PubMed ID: 11197211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
    Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl structure-function studies.
    Gaur M; Murphy GJ; deSauvage FJ; Leavitt AD
    Blood; 2001 Mar; 97(6):1653-61. PubMed ID: 11238104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
    Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
    Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
    Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
    Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
    Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
    Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.
    Hong Y; Dumènil D; van der Loo B; Goncalves F; Vainchenker W; Erusalimsky JD
    Blood; 1998 Feb; 91(3):813-22. PubMed ID: 9446641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.